Abstracts

A Recombinant HIV-1 Gag Virus Panel for the Evaluation of p24-Antibodies and HIV Diagnostic Tests

Background: Diagnostically, the HIV-1 p24 protein is currently only used in HIV-1/2 Ab + Ag combination screening tests (4th generation). However, there is growing interest in new test development to extend its use to diagnosing paediatric HIV infection and disease monitoring as inexpensive alternatives to PCR-based tests. Regarding the global HIV-1 diversity, such tests should…

Prevalence of Minority Resistant Variants to ETR DRV and RAL at Baseline in the ANRS 139 TRIO Trial

Background: ANRS 139 TRIO trial was a 96-week phase II non-comparative trial that evaluated the raltegravir (RAL), etravirine (ETR) and darunavir/r (DRV) combination in highly-experienced patients harboring multi-resistant viruses. 87% of the patients of the trial also received a NRTI- and/or ENFcontaining OBT regimen. A high level of virological suppression was observed with 93% of…

Antiretroviral-Naïve and -Treated Patients Can Harbor Viruses in CSF More Resistant Than in Plasma

Background: The neurological disorders in HIV-1 infected patients remained prevalent. The issue of whether HIV-1 in cerebrospinal fluid (CSF) originates from viral replication sources in central nervous system or from peripheral blood and the consequences on antiretroviral (ARV) resistance is still a subject of debate. In this study, the resistance of HIV-1 in plasma and…

Early ART Initiation Prevents Disruption of the Mucosal Barrier and Subsequent T-cell Activation

Background: Chronic HIV-infection is associated with damage of the intestinal epithelium partly by disrupting the Th17/Treg balance and contributing to systemic immune activation, a marker for disease progression. The initiation of anti-retroviral treatment (ART) early during acute HIV-infection (AHI) might represent an opportunity to intervene and limit destruction of the mucosal barrier. Methodology: 38 subjects…

Identification of IFI16 as HIV Restriction Factor

Background: Antiretroviral restriction factors are encoded by genes that are under strong positive selection pressure, induced in HIV-1 infection, and frequently interacting with viral proteins. Here, we used evolutionary genomics, transcriptomics, and protein interaction data to identify additional human genes showing these features and to characterize new restrictions factors. Methodology: We first performed a genome-wide…

Central Memory and Effector Memory CD4 T Cells From HIV Controllers Harbor Distinct HIV Strains

Background: The distinct immunologic functions performed by CD4 T cells of central memory (CM) and effector memory (EM) phenotypes require distinct gene expression programs that could differentially affect HIV replication. We tested the difference between CM and EM cells as HIV hosts in vivo by quantifying and sequencing HIV genomes from these cellular subsets in…